![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Poxviridae Infections - 25 Studies Found
Completed |
: Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults :
: 2005-11-24 : Biological: Smallpox vaccine, LISTER strain, from chick embryo cells |
Recruiting |
: IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo : Monkeypox Virus Infection : 2016-09-07 : Biological: IMVAMUNE® Two doses of attenuated live virus smallpox vaccine (IMVAMUNE®) administ |
Recruiting |
: Transcriptomics Signature of Anti Vaccinia Memory B Cells : Healthy : 2015-09-21 |
Completed |
: A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat : Smallpox : 2015-06-01 :
|
Recruiting |
: VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV : Smallpox Vaccine Adverse Reaction : 2015-05-06 : Biological: Vaccination with ACAM2000 In this study (VA-008), healthy adult male and female volunteers w |
Completed |
: VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults : Healthy Adult Immune Responses to Vaccine : 2015-04-03 :
|
Completed |
: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) :
: 2014-03-04 : Drug: Tecovirimat Oral tablet 600mg daily dose(three capsules, 200 mg/capsule) |
Active, not recruiting |
: A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® : 18-42 Year Old Healthy Vaccinia-naïve Subjects : 2013-07-26 :
|
Completed |
: Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® : Smallpox : 2013-04-04 : Biological: MVA Smallpox Vaccine Subjects receive two dose regimen of IMVAMUNE® (1x10^8 TCID50/0.5 |